Acumen Pharmaceuticals, Inc. Increase (Decrease) in Other Operating Assets
Acumen Pharmaceuticals, Inc. (ABOS) reported Increase (Decrease) in Other Operating Assets of $4.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-12
- Acumen Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $4.00K.
- Acumen Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $0.00.
- Acumen Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $2.00K.
- Acumen Pharmaceuticals, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$24.00K.
- Acumen Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2025 was -$40.00K.
- Acumen Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$74.00K, a 205.71% decline from fiscal 2023.
- Acumen Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2023 was $70.00K, a 48.91% decline from fiscal 2022.
- Acumen Pharmaceuticals, Inc. increase (decrease) in other operating assets for fiscal 2022 was $137.00K, a 878.57% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $4.00K 10-Q · filed 2026-08-12 | $6.00K derived: sum of 3 quarters · filed 2026-08-12 | -$18.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $2.00K derived: sum of 2 quarters · filed 2026-05-12 | -$22.00K derived: sum of 3 quarters · filed 2026-05-12 | -$24.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$22.00K derived: sum of 2 quarters · filed 2026-03-26 | -$24.00K derived: sum of 3 quarters · filed 2026-08-12 | -$40.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$26.00K derived: sum of 2 quarters · filed 2026-08-12 | -$42.00K 10-Q · filed 2025-11-12 | -$65.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$18.00K 10-Q · filed 2026-08-12 | -$41.00K derived: sum of 3 quarters · filed 2026-08-12 | -$99.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$16.00K 10-Q · filed 2026-05-12 | -$39.00K derived: sum of 2 quarters · filed 2026-05-12 | -$97.00K derived: sum of 3 quarters · filed 2026-05-12 | -$55.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$81.00K derived: sum of 2 quarters · filed 2026-03-26 | -$39.00K derived: sum of 3 quarters · filed 2026-03-26 | -$74.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | -$58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$16.00K derived: sum of 2 quarters · filed 2025-11-12 | -$51.00K 10-Q · filed 2025-11-12 | -$19.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $7.00K 10-Q · filed 2025-08-12 | $39.00K derived: sum of 3 quarters · filed 2025-08-12 | $20.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$35.00K 10-Q · filed 2025-05-13 | -$3.00K derived: sum of 2 quarters · filed 2025-05-13 | -$22.00K derived: sum of 3 quarters · filed 2025-05-13 | -$9.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $13.00K derived: sum of 2 quarters · filed 2025-03-27 | $26.00K derived: sum of 3 quarters · filed 2025-03-27 | $70.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$6.00K derived: sum of 2 quarters · filed 2024-11-12 | $38.00K 10-Q · filed 2024-11-12 | $97.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $57.00K 10-Q · filed 2024-08-13 | $116.00K derived: sum of 3 quarters · filed 2024-08-13 | $102.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $44.00K 10-Q · filed 2024-05-14 | $103.00K derived: sum of 2 quarters · filed 2024-05-14 | $89.00K derived: sum of 3 quarters · filed 2024-05-14 | $116.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $45.00K derived: sum of 2 quarters · filed 2024-03-26 | $72.00K derived: sum of 3 quarters · filed 2024-03-26 | $137.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $13.00K derived: sum of 2 quarters · filed 2023-11-13 | $78.00K 10-Q · filed 2023-11-13 | $79.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $92.00K 10-Q · filed 2023-08-08 | $93.00K derived: sum of 3 quarters · filed 2023-08-08 | $93.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $65.00K 10-Q · filed 2023-05-09 | $66.00K derived: sum of 2 quarters · filed 2023-05-09 | $66.00K derived: sum of 3 quarters · filed 2023-05-09 | $66.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $1.00K derived: sum of 2 quarters · filed 2023-03-27 | $1.00K derived: sum of 3 quarters · filed 2023-03-27 | $14.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $13.00K 10-Q · filed 2022-11-14 | -$509.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $13.00K 10-Q · filed 2022-08-15 | -$509.00K derived: sum of 3 quarters · filed 2022-08-15 | -$401.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-16 | -$509.00K derived: sum of 2 quarters · filed 2022-05-16 | -$401.00K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$414.00K derived: sum of 2 quarters · filed 2022-03-28 | -$144.00K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $378.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $270.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |